These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7601942)

  • 1. Natural killer cell and lymphokine-activated killer cell activity against melanocytes in vitiligo.
    Durham-Pierre DG; Walters CS; Halder RM; Pham HN; Vanderpool EA
    J Am Acad Dermatol; 1995 Jul; 33(1):26-30. PubMed ID: 7601942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cell-mediated cytotoxicity in vitiligo.
    Ghoneum M; Grimes PE; Gill G; Kelly AP
    J Am Acad Dermatol; 1987 Oct; 17(4):600-5. PubMed ID: 3668006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.
    Manning LS; Bowman RV; Darby SB; Robinson BW
    Am Rev Respir Dis; 1989 Jun; 139(6):1369-74. PubMed ID: 2786360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition.
    Mueller EA; Anderer FA
    Cancer Res; 1990 Jun; 50(12):3646-51. PubMed ID: 1692765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.
    Gardiner CM; Reen DJ
    Immunology; 1998 Apr; 93(4):511-7. PubMed ID: 9659223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin.
    Shau H; Kim A; Golub SH
    J Leukoc Biol; 1992 Apr; 51(4):343-9. PubMed ID: 1564398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
    Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
    Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo.
    Mozzanica N; Villa ML; Foppa S; Vignati G; Cattaneo A; Diotti R; Finzi AF
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):693-700. PubMed ID: 1316387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP; Manning LS; Robinson BW
    Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
    Shau HY; Golub SH
    J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible inhibition of lymphokine-activated killer cell activity by lipoxygenase-pathway inhibitors.
    Sibbitt WL; Imir T; Bankhurst AD
    Int J Cancer; 1986 Oct; 38(4):517-21. PubMed ID: 3019899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
    Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro glioma cell cytotoxicity of LAK cells from glioma patients and healthy subjects.
    Bosnes V; Hirschberg H
    J Neurosurg; 1988 Aug; 69(2):234-8. PubMed ID: 3260622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.